发明名称 Oral pharmaceutical compositions with controlled release and prolonged absorption
摘要 The invention concerns a galenic system with prolonged/controlled release of the medicinal and/or nutritional active principle, for oral administration. The aim is to provide a system enabling to obtain with one single tolerable and acceptable dose of active principle, efficient therapeutic protection over 24 hours (increasing the bioabsorption time without affecting bioavailability). To achieve this, the invention provides a composition comprising two controlled release systems associated in series, namely: individualised coated particles (microcapsules) of active principle forming an internal phase, the coating comprising a film-forming polymer P<SUB>1 </SUB>(ethylcellulose), a nitrogenous polymer (polyvinylpyrrolidone), a softener (castor oil) and a lubricant (magnesium stearate), and an external phase of functional carriers: polyelectrolytic hydrophilic polymer: (alginate), neutral hydrophilic polymer (hydroxypropylmethylcellulose) and a gelling additive (calcium acetate), said composition spontaneously forming in the presence of water, a cohesive and stable composite macroscopic solid, wherein the external continuous phase is a gelled matrix including the active principle microcapsules. The invention is useful for delayed oral galenic formulation of metformin.
申请公布号 US2007207214(A1) 申请公布日期 2007.09.06
申请号 US20070723553 申请日期 2007.03.21
申请人 FLAMEL TECHNOLOGIES 发明人 CASTAN CATHERINE;LEGRAND VALERIE;MEYRUEIX REMI;SOULA GERARD
分类号 A61J3/07;A61K9/14;A61K9/20;A61K9/22;A61K9/48;A61K9/50;A61K9/62;A61K9/64;A61K31/155;A61K47/12;A61K47/14;A61K47/32;A61K47/36;A61K47/38;A61K47/42;A61P3/10 主分类号 A61J3/07
代理机构 代理人
主权项
地址